News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 179696

Wednesday, 06/18/2014 12:21:19 AM

Wednesday, June 18, 2014 12:21:19 AM

Post# of 347009
Dmitry Gabrilovich : Peregrine Pharmaceuticals KOL :

Dmitry, the MD talking MDSC's on the verge of heading to Greece re: Notch Signaling conference.... is heading up a brand new tumor immunology program: Translational Tumor Immunology

----------------

Translational Tumor Immunology Faculty positions
Institution: The Wistar Institute
Location: Philadelphia, PA
Category:

Faculty - Science - Biochemistry and Molecular Biology

Posted: 06/17/2014
Application Due: Open Until Filled
Type: Full Time
Notes: included on Affirmative Action email

The Wistar Institute is seeking outstanding candidates at all ranks for faculty positions in the newly created program in Translational Tumor Immunology, where they will be expected to develop or expand their extramurally-funded research programs in different areas of tumor immunology and tumor microenvironment.

Specific areas of interest include and are not limited to: molecular and cellular mechanisms regulating immune responses in cancer; novel approaches to therapeutic manipulation of the immune system in cancer; the role of metabolic changes in the function of the immune system in cancer; the impact of conventional and targeted cancer therapeutics on the immune system; interaction between cells of the immune system and epithelium/endothelium/stroma. Interest in translational research is desirable.

The Wistar Institute, an NCI-designated Cancer Center and independent research institute in Philadelphia, offers highly competitive start-up support packages including salary and fringe benefits, a superb and interactive research environment in a newly constructed state-of-the-art research tower and animal facility, and outstanding core facilities in proteomics, genomics, microscopy, high-throughput molecular screening, bioinformatics, and flow cytometry.

Investigators have access to a wide range of clinical materials through a partnership with the Helen F. Graham Cancer Center, Newark, DE. The Institute's location, near the University of Pennsylvania campus, provides opportunities for academic and clinical collaborations. Graduate students at Philadelphia academic institutions frequently receive training at The Wistar Institute.

Applications will be reviewed as received and will be accepted until the positions are filled. To ensure timely consideration, applications should be submitted before September 1, 2014. The application should include: a curriculum vitae, a brief summary of past and future research interests, a history of research funding support (if applicable), and the names of three referees (submitted as a single PDF). Applications should be sent by e-mail to: Dmitry Gabrilovich, Search Committee Chair, c/o Maria Colelli ( colelli@wistar.org), The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104.
Application Information
Contact: Dmitry Gabrilovich, Search Committee Chair, c/o Maria Colelli
The Wistar Institute
Email Address: colelli@wistar.org

http://www.higheredjobs.com/search/details.cfm?Jobcode=175910045&aID=&print=yes

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y